Chengdu Suncadia Medicine Co., Ltd.
Clinical trials sponsored by Chengdu Suncadia Medicine Co., Ltd., explained in plain language.
-
New hope for kidney disease: HRS-5965 aims to slow IgA nephropathy
Disease control Not yet recruitingThis study tests the long-term safety of an experimental drug, HRS-5965, in 380 adults with primary IgA nephropathy, a kidney disease. The goal is to see if the drug can reduce protein in the urine and help preserve kidney function over time. Participants must have completed a pr…
Phase: PHASE2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Healthy volunteers needed to test new heart Drug's safety
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and tolerability of a new drug called HRS-5765 in 74 healthy adults aged 18-65. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. This study does n…
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC